Researchers Study Use of Dasatinib for Patients With High-Risk MDS

The therapy may not be effective for all patients, but those with trisomy 8 chromosomal disorder have higher rates of stable disease and respond better to treatment with dasatinib, the study shows.

http://www.sciencedaily.com/releases/2013/03/130321105107.htm